
Partner
201-896-7115 dmckillop@sh-law.comFirm Insights
Author: Daniel T. McKillop
Date: February 2, 2018

Partner
201-896-7115 dmckillop@sh-law.comThe deadly opioid epidemic shows no signs of slowing down, despite the widespread attention it is finally receiving. At least 1,901 people died from opioid overdoses in New Jersey in 2016.

As lawmakers and public health officials grapple with how best to combat the opioid crisis, medical marijuana is emerging as a safer tool to manage pain. A new report from the National Academies of Sciences, Engineering, and Medicine, which represents one of the most comprehensive studies of recent research on the health effects of cannabis, concluded there is “strong evidence” that cannabis is effective at managing chronic pain in adults relative to a placebo.
Drug overdose deaths involving opioids have skyrocketed in recent years. Below are several startling statistics from the Centers for Disease Control and Prevention:
Several factors have contributed to the rapid increase in opioid-related overdoses, including a rise on prescriptions for the potent painkillers. Since 1999, the number of prescription opioids sold in the U.S. nearly quadrupled. However, there has not been an overall change in the amount of pain that Americans report.
The majority of opioid deaths involve individuals with no history of substance abuse. In many cases, opioid addiction starts with a valid prescription after surgery or other medical treatment. Once the opioid medication runs out or becomes too expensive, people often turn to street drugs like heroin.
In 2013, providers wrote nearly a quarter of a billion opioid prescriptions, which is enough for every American adult to have their own bottle of pills. Opioids are also increasingly prescribed for chronic pain. Although they may provide short-term relief, the medications have not proven to be an effective long-term solution.
New Jersey legalized medical marijuana in 2010 with the enactment of the New Jersey Compassionate Use Medical Marijuana Act (the “Act”). The New Jersey Department of Health implemented the Act by creating the New Jersey Medical Marijuana Program (“MMP”). The MMP authorizes approved physicians to disburse up to two ounces of medical marijuana to a registered patient during any 30-day period to treat numerous “debilitating medical conditions,” particularly where conventional treatments are ineffective or exacerbate a patient’s suffering.
The Garden State’s medical marijuana program is one of the strictest in the country.
A physician must certify that a patient has an approved debilitating medical condition to participate in the New Jersey Medicinal Marijuana Program. The current list of qualifying conditions for medical marijuana includes amyotrophic lateral sclerosis (Lou Gehrig’s disease), Multiple Sclerosis, terminal cancer, muscular dystrophy, inflammatory bowel disease, and any terminal illness. Post-traumatic stress disorder (PTSD) was added as an approved condition in 2016.
In July, the New Jersey Medicinal Marijuana Review Panel (MMRP) recommended that the Commissioner of the Department of Public Health qualify dozens of additional debilitating conditions falling within the categories of chronic pain, migraine, anxiety, and Tourette’s Syndrome for inclusion in the State’s medicinal marijuana program. However, the Department of Public Health has yet to render a final decision.
Research confirms that cannabis can be an effective pain management tool. Moreover, encouraging the prescription of medical marijuana can help curb opioid addiction. Unlike narcotic painkillers, cannabis can’t lead to a fatal overdose. The likelihood of addiction is also much lower.
A 2015 working paper by the National Bureau of Economic Research found that the existence of medical marijuana dispensaries in a state was linked to a 15 to 35 percent decrease in admissions to substance abuse treatment centers. It further found a similar decline in overdose deaths.
In Colorado, legalizing recreational cannabis resulted in a decline in opioid overdose deaths. According to a study published in the American Journal of Public Health, in the two years after Colorado implemented its recreational marijuana law, opioid deaths dropped by 6.5 percent. A 2014 study by the Johns Hopkins Bloomberg School of Public Health found similar results. The researchers estimated that prescription drug overdoses decrease 25 percent in states with medical marijuana programs that allow chronic pain patients to participate. Moreover, the effect of legalizing medical cannabis appeared to grow over time, meaning more lives were saved each additional year after the law was enacted.
While Gov. Chris Christie made the opioid crisis a top priority, he strongly opposed medical marijuana. With a change in leadership in the Garden State, it is more likely that cannabis may be considered as a viable solution to the growing health crisis of opioid overdoses.
This article is a part of a series pertaining to cannabis legalization in New Jersey and the United States at large. Prior articles in this series are below:
If you have any questions or if you would like to discuss the matter further, please contact me, Dan McKillop, at 201-806-3364.
Disclaimer: Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy. Legal advice provided by Scarinci Hollenbeck, LLC is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Scarinci Hollenbeck, LLC will not provide assistance in circumventing Federal or state cannabis law or policy, and advice provided by our office should not be construed as such.
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.

When an employee raises a complaint of harassment, discrimination, retaliation, or other workplace misconduct, an employer’s response can have significant legal consequences. A prompt, impartial, and well-documented workplace investigation can help employers address potential wrongdoing, protect employees, and reduce the risk of costly employment litigation. For New Jersey and New York businesses, understanding when to […]
Author: Angelo Auteri

Federal gift tax rules allow individuals to transfer significant assets to loved ones without incurring gift taxes, but taking full advantage of these opportunities requires an understanding of the applicable limits and deadlines. With the annual gift tax exclusion set to increase in 2027, now is a good time to review the current rules and […]
Author: Marc J. Comer

Battery energy storage systems (BESS) are being developed throughout New Jersey, New York, and Pennsylvania, with much of the legal attention focused on zoning approvals, permitting, interconnection, and safety requirements. Far less attention has been paid to what happens when these facilities reach the end of their operating lives. For developers and property owners entering […]
Author: Nicholas Wall

While most estate and trust administrations conclude without significant complications, disagreements can arise over expenses, fiduciary commissions, distributions, and other aspects of the administration. Understanding the steps involved, as well as the fiduciary’s legal obligations, can help avoid unnecessary disputes and bring the administration to a successful conclusion. Key Takeaways Keeping Beneficiaries Informed Throughout the […]
Author: Marc J. Comer

A Fort Monmouth redevelopment agreement imposes obligations beyond a traditional property purchase, including construction deadlines, financial commitments, permitted uses, and restrictions on future transfers. Fort Monmouth’s ongoing redevelopment presents significant opportunities for real estate developers, investors, and businesses seeking to establish or expand their presence in Monmouth County. However, acquiring and developing property at the […]
Author: Donald M. Pepe

As battery energy storage system (BESS) projects move from planning to construction, developers and property owners must address an issue that extends well beyond zoning approvals and interconnection agreements: what happens when something goes wrong? To avoid unforeseen liability, developers should address fire code compliance, emergency response planning, contractual risk allocation, and environmental liability before […]
Author: Nicholas Wall
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!